CD&R (or the "Firm") today announced that John Chiminski, former Chair and Chief Executive Officer of Catalent, Inc., has been engaged as an Operating Advisor to CD&R funds. John brings more than three decades of leadership experience across the healthcare, pharmaceutical and pharma services sectors and will advise the Firm on investment opportunities and value-creation initiatives within its healthcare vertical.
TAMPA, Fla. & DALLAS, July 07, 2026--Catalent & Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene Therapy, MCO-010
This is the newest page. Registered accounts read further back.